Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandra Valdivielso-Moré has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effectiveness of a nurse-led telemedicine-based program for pharmacological and prognostic optimization of patients with heart failure and reduced ejection fraction: the MAR-HF-Titration study

    by Sonia Ruiz-Bustillo, Miren Vicente, Pilar Ruiz-Rodriguez, Ana María Linás-Alonso, Sandra Valdivielso-Moré, Núria Farré, Laia Belarte-Tornero, Ronald Morales-Murillo, Joan Vime-Jubany, Neus Badosa, et al.

    Aims: Guidelines emphasize the importance of quadruple therapy in heart failure with reduced ejection fraction (HFrEF), and of achieving target doses quickly. The aim of the MAR-HF-Titration study was to assess the effectiveness of a nurse-led, telemedicine programme for this purpose. Methods and results: Prospective study including 210 HFrEF patients between September 2021 and December 2023. The 6-month follow-up used a telemedicine programme involving daily telemonitoring of vital signs, weight and symptoms, routine laboratory test monitoring, videoconferences and the use of algorithms for drug titration. Mean age was 70 years, 35% women. Mean left ventricle ejection fraction (LVEF) was 31%, 60% had a non-ischaemic aetiology, and 61% newly diagnosed HF. After the intervention, significant increases were achieved in the use of quadruple therapy at any dose (63 vs. 75%; P = 0.001), at ≥50% of the target doses of each drug (10 vs. 44%, P < 0.001), and at target doses of all drugs (0 vs. 19%, P < 0.001). Median titration time was 45 days for beta-blockers, 65 for MRA, and 69 for ARNI. Older age, chronic kidney disease, hypotension, and higher NTproBNP were associated with lower odds of effective titration. The LVEF increased (31–45%, P < 0.001) and the NTproBNP values were significantly reduced (1960–806 pg/mL, P < 0.001). Increases in the use of prognostic medications were also observed in a sub-analysis restricted to participants aged ≥75 years. Conclusion: Our intensive, nurse-led, telemedicine-based programme attained a fast optimization of prognostic therapies in HFrEF and resulted in significant improvements in parameters with prognostic relevance.


  • Open Access

    Characteristics of Patients with Heart Failure and Advanced Chronic Kidney Disease (Stages 4–5) Not Undergoing Renal Replacement Therapy (ERCA-IC Study)

    by Sandra Valdivielso Moré, Miren Vicente Elcano, Anna García Alonso, Sergi Pascual Sanchez, Isabel Galceran Herrera, Francesc Barbosa Puig, Laia C. Belarte-Tornero, Sonia Ruiz-Bustillo, Ronald O. Morales Murillo, Clara Barrios, et al.

    Background: Despite the frequent coexistence of heart failure (HF) in patients with advanced chronic kidney disease (CKD), it has been understudied, and little is known about its prevalence and prognostic relevance. Methods: A retrospective study of 217 patients with advanced CKD (stages 4 and 5) who did not undergo renal replacement therapy (RRT). The patients were followed up for two years. The primary outcome was all-cause death or the need for RRT. Results: Forty percent of patients had a history of HF. The mean age was 78.2 ± 8.8 years and the mean eGFR was 18.4 ± 5.5 mL/min/1.73 m2. The presence of previous HF identified a subgroup of high-risk patients with a high prevalence of cardiovascular comorbidities and was significantly associated with the composite endpoint of all-cause hospitalization or need for RRT (66.7% vs. 53.1%, HR 95% CI 1.62 (1.04–2.52), p = 0.034). No differences were found in the need for RRT (27.6% vs. 32.2%, p = 0.46). Nineteen patients without HF at baseline developed HF during the follow-up and all-cause death was numerically higher (36.8 vs. 19.8%, p = 0.1). Conclusions: Patients with advanced CKD have a high prevalence of HF. The presence of previous HF identified a high-risk population with a worse prognosis that required close follow-up.


  • Prognostic value of apical rocking and septal flash after cardiac resynchronization

    by Sonia Ruiz Bustillo, Ana García Durán, Alicia Calvo Fernández, Aleksandra Mas-Stachurska, Francisco Escalante, Ermengol Vallès, Jesús Jiménez López, Laia Belarte Tornero, Sandra Valdivielso More, Eduard Solé González, et al.


  • Open Access

    Quality of Life in Older Patients after a Heart Failure Hospitalization: Results from the SENECOR Study

    by Daniele Luiso, Marta Herrero-Torrus, Neus Badosa, Cristina Roqueta, Sonia Ruiz-Bustillo, Laia C. Belarte-Tornero, Sandra Valdivielso-Moré, Ronald O. Morales, Olga Vázquez, Núria Farré

    Background: Information about health-related quality of life (HRQoL) in heart failure (HF) in older adults is scarce. Methods: We aimed to describe the HRQoL of the SENECOR study cohort, a single-center, randomized trial comparing the effects of multidisciplinary intervention by a geriatrician and a cardiologist (intervention group) to that of a cardiologist alone (control group) in older patients with a recent HF hospitalization. Results: HRQoL was assessed by the short version of the disease-specific Kansas Cardiomyopathy Questionnaire (KCCQ-12) in 141 patients at baseline and was impaired (KCCQ-12 < 75) in almost half of the cohort. Women comprised 50% of the population, the mean age was 82.2 years, and two-thirds of patients had preserved ejection fraction. Comorbidities were highly prevalent. Patients with impaired HRQoL had a worse NYHA functional class, a lower NT-proBNP, a lower Barthel index, and a higher Clinical Frailty Scale. One-year all-cause mortality was 22.7%, significantly lower in the group with good-to-excellent HRQoL (14.5% vs. 30.6%; hazard ratio 0.28; 95% confidence interval 0.10–0.78; p = 0.014). In the group with better HRQoL, all-cause hospitalization was lower, and there was a trend towards lower HF hospitalization. Conclusions: The KCCQ-12 questionnaire can provide inexpensive prognostic information even in older patients with HF. (Funded by grant Primitivo de la Vega, Fundación MAPFRE. ClinicalTrials number, NCT03555318).


  • Open Access

    Randomized Controlled Trial Comparing a Multidisciplinary Intervention by a Geriatrician and a Cardiologist to Usual Care after a Heart Failure Hospitalization in Older Patients: The SENECOR Study

    by Marta Herrero-Torrus, Neus Badosa, Cristina Roqueta, Sonia Ruiz-Bustillo, Eduard Solé-González, Laia C. Belarte-Tornero, Sandra Valdivielso-Moré, Olga Vázquez, Núria Farré

    Background: The prognosis of older patients after a heart failure (HF) hospitalization is poor. Methods: In this randomized trial, we consecutively assigned 150 patients 75 years old or older with a recent heart failure hospitalization to follow-up by a cardiologist (control) or follow-up by a cardiologist and a geriatrician (intervention). The primary outcome was all-cause hospitalization at a one-year follow-up. Results: All-cause hospitalization occurred in 47 of 75 patients (62.7%) in the intervention group and in 58 of 75 patients (77.3%) in the control group (hazard ratio, 0.67; 95% confidence interval, 0.46 to 0.99; p = 0.046). The number of patients with at least one HF hospitalization was similar in both groups (34.7% in the intervention group vs. 40% in the control group, p = 0.5). There were a total of 236 hospitalizations during the study period. The main reasons for hospitalization were heart failure (38.1%) and infection (14.8%). Mortality was 24.7%. Heart failure was the leading cause of mortality (54.1% of all deaths), without differences between groups. Conclusions: A follow-up by a cardiologist and geriatrician in older patients after an HF hospitalization was superior to a cardiologist’s follow-up in reducing all-cause hospitalization in older patients. (Funded by Beca Primitivo de la Vega, Fundación MAPFRE. ClinicalTrials.gov number, NCT03555318).


  • Risk stratification in heart failure. A new score for risk assessment in ambulatory patients with chronic heart failure

    by Sandra Valdivielso-More, Laia Carla Belarte-Tornero, Núria Farré

  • Influence of cardiovascular disease and cardiovascular risk factors in COVID-19 patients. Data from a large prospective Spanish cohort

    by Marcos García-Guimaraes, Diana Mojón, Alicia Calvo, Andrea Izquierdo, Laia Belarte-Tornero, Neus Salvatella, Marc Llagostera, Alejandro Negrete, Aleksandra Mas-Stachurska, Sonia Ruiz, et al.


  • Open Access

    Prognostic Implications of Chronic Heart Failure and Utility of NT-proBNP Levels in Heart Failure Patients with SARS-CoV-2 Infection

    by Laia C. Belarte-Tornero, Sandra Valdivielso-Moré, Miren Vicente Elcano, Eduard Solé-González, Sonia Ruíz-Bustillo, Alicia Calvo-Fernández, Isaac Subinara, Paula Cabero, Cristina Soler, Héctor Cubero-Gallego, et al.

    Background: The prevalence and prognostic value of chronic heart failure (CHF) in the setting of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has seldom been studied. The aim of this study was to analyze the prevalence and prognosis of CHF in this setting. Methods: This single-center study included 829 consecutive patients with SARS-CoV-2 infection from February to April 2020. Patients with a previous history of CHF were matched 1:2 for age and sex. We analyze the prognostic value of pre-existing CHF. Prognostic implications of N terminal pro brain natriuretic peptide (NT-proBNP) levels on admission in the CHF cohort were explored. Results: A total of 129 patients (43 CHF and 86 non-CHF) where finally included. All-cause mortality was higher in CHF patients compared to non-CHF patients (51.2% vs. 29.1%, p = 0.014). CHF was independently associated with 30-day mortality (hazard ratio (HR) 2.3, confidence interval (CI) 95%: 1.26–2.4). Patients with CHF and high-sensitivity troponin T < 14 ng/L showed excellent prognosis. An NT-proBNP level > 2598 pg/mL on admission was associated with higher 30-day mortality in patients with CHF. Conclusions: All-cause mortality in CHF patients hospitalized due to SARS-CoV-2 infection was 51.2%. CHF was independently associated with all-cause mortality (HR 2.3, CI 95% 1.26–4.2). NT-proBNP levels could be used for stratification risk purposes to guide medical decisions if larger studies confirm this finding.


  • Transthyretin Cardiac Amyloidosis: Patient Characteristics in Our Region

    by Sonia Ruiz Bustillo, Jose María Moreno Coca, Sandra Valdivielso More, Eduard Sole Gonzalez, Laia Carla Belarte Tornero, Mireia Ble Gimeno, Nuria Farre López


  • Open Access

    Contemporary Yield of 24-hour Holter Monitoring: Role of Inter-Atrial Block Recognition

    by Bazan Victor, Cediel German, Llibre Cinta, Sarrias Axel, Romeo Isabel, Ibars Sònia, Escudero Francisco, Valdivielso Sandra, Bisbal Felipe, Villuendas Roger, et al.

    Background The diagnostic yield of 24-hour ECG Holter monitoring (24H) is currently overcome by alternative ECG monitoring techniquesand it needs to be optimized. The recognition of inter-atrial block (IAB) has emerged as a reliable indicator of patients at risk of atrial fibrillation relapses, and its role enhancing the yield of 24H is yet to be determined. We hypothesized that a presumably low yield of 24H may be ameliorated by means of incorporating the assessment for IAB. Methods We retrospectively analyzed 1017 consecutive 24H registers performed in a Multidisciplinary Integrated Health Care Institution, in which a restrictive definition of diagnostic 24H findings was used. A univariate and multivariate regression analysis served to determine the variables associated with a higher 24H’s yield, including the requesting medical specialty, type of indication and a number of clinical, echocardiographic and ECG variables, including IAB. Results The mean age of our population was 62 ± 17 years (55% males). The majority of 24H were indicated from the Cardiology department (48%). The overall yield was 12.8%, higher for the assessment of the integrity of the electrical conduction system (26.1%) and poorer for the assessment of syncope (3.2%) and cryptogenic stroke (4.6%). The variables associated with higher diagnostic performance were indication from Cardiology (p < 0.001), IAB (p = 0.004), structural heart disease (p = 0.008) and chronic renal failure (p = 0.009). Patients ≤ 50 years old only retrieved a 7% yield. In the multivariate analysis, indication from Cardiology and IAB remained significant predictors of higher 24H’s yield. In a secondary analysis including echocardiographic data, only identification of IAB remained statistically significant. Conclusions The recognition of IAB and the type of indication are major determinants of a higher 24H’s diagnostic yield and may help to optimize the selection of candidates.